Browsing Tag
Island Pharmaceuticals Limited
3 posts
Island Pharmaceuticals (ASX:ILA) shares rise as Texas Biomed expands Galidesivir regulatory pathway
Island Pharmaceuticals adds Texas Biomed to Galidesivir’s FDA Animal Rule program, expanding dose evidence while raising execution and timing stakes now.
July 13, 2026
Island Pharmaceuticals (ASX: ILA) targets Marburg stockpile deal after FDA greenlights Animal Rule
Island Pharmaceuticals gets FDA Animal Rule nod for Galidesivir in Marburg. Find out how it could unlock US$155M in value and stockpile contracts.
November 17, 2025
Is Island Pharmaceuticals (ASX: ILA) set for a breakout? Galidesivir awaits critical FDA decision
Island Pharmaceuticals secures FDA response timeline for Galidesivir. Find out how it may accelerate Marburg approval under the Animal Rule pathway.
October 22, 2025